Crohn's disease with gastric localization
Gnoni, G.; Beati, C.; Marni, A.
Minerva Chirurgica 38(11): 787-791
1983
ISSN/ISBN: 0026-4733 PMID: 6888735 Document Number: 215418
Document emailed within 1 workday
Related Documents
Kruis, W.; Pfaff, G.; Lamerz, R.; Eisenburg, J. 1977: CEA blood level in patients with Crohn's disease with reference to localization, duration and severity of the disease Fortschritte der Medizin 95(47-48): 2795-2798Stanciu, C.; Triandaf, N. 1977: Crohn's disease of colonic localization Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 81(2): 307-309
Goebell, H.; Wienbeck, M.; Schomerus, H.; Malchow, H. 1990: Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study Medizinische Klinik 85(10): 573-576
Delumeau, G.; Toscer, L. 1971: Gastric localization of Hodgkin's disease La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 47(23): 1496-1498
Fiz, G.; Vital, C. 1971: Gastric localization of Hodgkin's disease Bordeaux Medical 4(2): 399 Passim
Patel, M.; Banerjee, B.; Block, J.G.; Marshall, J.B. 1997: Gastric Crohn's disease complicated by adenocarcinoma of the stomach: case report and review of the literature American Journal of Gastroenterology 92(8): 1368-1371
Talseth, T. 1976: Isolated gastric involvement in Crohn's disease. Report of a case simulating scirrhus carcinoma Acta Chirurgica Scandinavica 142(8): 611-613
Gavriliţa, L.; Miron, E. 1977: Cytomegalic inclusion disease of gastric localization in adults Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 81(2): 311-312
Auer, I.O.; Röder, A.; Mittelstaedt, A. 1985: Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease Fortschritte der Medizin 103(46): 1076-1080
Mirecka, J.; Marx, D.; Schauer, A. 1995: Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer Anticancer Research 15(4): 1459-1465
Etienne, A.M.; Dupuis, G. 2011: Maladie de Crohn et qualité de vie: des pistes d'intervention : Etudes cliniques récentes en thérapie comportementale et cognitive chez l'enfant, l'adolescent et l'adulte - Crohn's disease and quality of life: methods of intervention Perspectives Psychiatriques (Paris) 50(3): 246-255
Elsner, J.; Kiehl, P.; Kapp, A.; Weiss, J. 1996: Erythema elevatum et diutinum bei Morbus Crohn : Klinischer Verlauf als Hinweis einer gemeinsamen Ätiologie ? - Erythema elevatum diutinum and Crohn's disease. Clinical course as evidence of a common etiology ? Hautarzt 47(9): 701-704
Telleschi, S.; Terzani, E. 1969: Case of gastric localization of tuberculosis Archivio "de Vecchi" Per l'Anatomia Patologica E la Medicina Clinica 55(2): 439-457
Kirsner, J.B. 1999: "Nonspecific" inflammatory bowel disease (ulcerative colitis and Crohn's disease) after 100 years--what next? Italian Journal of Gastroenterology and Hepatology 31(8): 651-658
Puleo, A.; Cappello, M.; Orlando, A.; Dardanoni, G.; Oliva, L.; Cottone, M. 1986: An evaluation of the laboratory parameters useful in the determination of disease activity in Crohn disease Recenti Progressi in Medicina 77(11): 511-514
Akolkar, P.N.; Gulwani-Akolkar, B.; Heresbach, D.; Lin, X.Y.; Fisher, S.; Katz, S.; Silver, J. 1997: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease American Journal of Gastroenterology 92(12): 2241-2244
Bamba, S.; Tsujikawa, T.; Ban, H.; Imaeda, H.; Inatomi, O.; Nishida, A.; Sasaki, M.; Andoh, A.; Fujiyama, Y. 2014: Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease Hepato-Gastroenterology 61(131): 689-696
Doe, W.F.; Booth, C.C.; Brown, D.L. 1973: Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis Lancet 1(7800): 402-403
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705
Houman, M.H.; Doghri, A.; Boubaker, J.; Kchir, M.N.; Mahdhaoui, A.; Filali, A.; Miled, M. 1996: Takayasu disease in Crohn disease: an exceptional association Annales de Gastroenterologie et d'Hepatologie 31(6): 337-340